Roberto Cuca - 07 Jun 2022 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role: COO and CFO
Issuer symbol: TELA
Report date: 07 Jun 2022
Net transaction value: +$82,500
Form type: 4
Accepted by SEC: 07 Jun 2022, 16:05:21 UTC
Previous filing: 25 Feb 2022
Next filing: 27 Feb 2023
SEC filing: View on sec.gov
Reporting owner signature: /s/ Megan Smeykal, Attorney-in-fact

Key filing fact

Roberto Cuca filed Form 4 for TELA Bio, Inc. (TELA) on 07 Jun 2022.

Key facts

This page summarizes Roberto Cuca's Form 4 filing for TELA Bio, Inc. (TELA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Jun 2022, 16:05.

Change

Previous filing in this sequence was filed on 25 Feb 2022.
Current net transaction value: +$82,500.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TELA transaction

Common Stock

Purchase

Transaction value: $82,500
Shares: +15,000
Change %: +75%
Price: $5.50
Shares after: 34,892
Date: 07 Jun 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $5.28 to $5.62. The Reporting Person undertakes to provide TELA Bio, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.